Christopher D. Turner
Impact in
- Genetics top 1%
- Glioma Diagnosis and Treatment
- Chronic Lymphocytic Leukemia Research
- Hematology top 2%
- Chronic Myeloid Leukemia Treatments
Papers in
- Genetics 31
- Glioma Diagnosis and Treatment 15
- Chronic Lymphocytic Leukemia Research 14
-
- Lung Cancer Treatments and Mutations 11
- Brain Metastases and Treatment 7
- Co-authors
- Anthony H.V. Schapira (5 shared papers)Christine Chordas (4 shared papers)Narayana I. Narasimhan (4 shared papers)Jonathan M. Cooper (3 shared papers)Celiane Rey‐Casserly (2 shared papers)Cori Liptak (2 shared papers)Victor M. Rivera (11 shared papers)Hagop M. Kantarjian (12 shared papers)
- Journals
- Journal of Clinical Oncology (17 papers)Blood (4 papers)Annals of Oncology (4 papers)Pediatric Blood & Cancer (2 papers)Journal of Thoracic Oncology (2 papers)
- Partner nations
- United StatesUnited KingdomFrance
In The Last Decade
Christopher D. Turner
65 papers receiving 2.5k citations
Hit Papers
Peers
Comparison fields: 5 of 108
- Genetics 837
- Hematology 628
- Neurology 402
- Internal Medicine 91
- Rheumatology 317
Countries citing papers authored by Christopher D. Turner
This map shows the geographic impact of Christopher D. Turner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher D. Turner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher D. Turner more than expected).
Fields of papers citing papers by Christopher D. Turner
This network shows the impact of papers produced by Christopher D. Turner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher D. Turner. The network helps show where Christopher D. Turner may publish in the future.
Co-authors
The 25 scholars most cited alongside Christopher D. Turner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 67 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Ponatinib in Refractory Philadelphia Chromosome–Positive Leukemias Hit paper breakdown → | 2012 | 527 |
| 2 | 2007 | 205 | |
| 3 | 2005 | 163 | |
| 4 | 2009 | 138 | |
| 5 | 2005 | 125 | |
| 6 | 1991 | 98 | |
| 7 | 1991 | 91 | |
| 8 | 2019 | 84 | |
| 9 | 2007 | 74 | |
| 10 | 2002 | 63 | |
| 11 | 2015 | 59 | |
| 12 | 2009 | 57 | |
| 13 | 2020 | 57 | |
| 14 | 2006 | 50 | |
| 15 | 2007 | 46 | |
| 16 | 2020 | 44 | |
| 17 | 1991 | 43 | |
| 18 | 2021 | 39 | |
| 19 | 2010 | 36 | |
| 20 | 2007 | 34 |
About Christopher D. Turner
Christopher D. Turner is a scholar working on Genetics, Pulmonary and Respiratory Medicine, Molecular Biology, Hematology and Oncology, having authored 67 papers that have together received 2.5k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (15 papers), Chronic Myeloid Leukemia Treatments (15 papers), Chronic Lymphocytic Leukemia Research (14 papers), Acute Lymphoblastic Leukemia research (11 papers), Lung Cancer Treatments and Mutations (11 papers), Brain Metastases and Treatment (7 papers), Genetic Neurodegenerative Diseases (7 papers) and Mitochondrial Function and Pathology (5 papers). The work is most often cited by research in Genetics (837 citations), Hematology (628 citations), Neurology (402 citations), Internal Medicine (91 citations) and Rheumatology (317 citations). Christopher D. Turner has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Anthony H.V. Schapira, Christine Chordas, Narayana I. Narasimhan, Jonathan M. Cooper, Celiane Rey‐Casserly, Cori Liptak, Victor M. Rivera, Hagop M. Kantarjian, Jörge E. Cortes and Moshe Talpaz. Their work appears in journals such as Journal of Clinical Oncology, Blood, Annals of Oncology, Pediatric Blood & Cancer and Journal of Thoracic Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.